131 related articles for article (PubMed ID: 21073321)
1. Investigation of drug release from pellets coated with different shellac types.
Farag Y; Leopold CS
Drug Dev Ind Pharm; 2011 Feb; 37(2):193-200. PubMed ID: 21073321
[TBL] [Abstract][Full Text] [Related]
2. Development of shellac-coated sustained release pellet formulations.
Farag Y; Leopold CS
Eur J Pharm Sci; 2011 Mar; 42(4):400-5. PubMed ID: 21251975
[TBL] [Abstract][Full Text] [Related]
3. Influence of the inlet air temperature in a fluid bed coating process on drug release from shellac-coated pellets.
Farag Y; Leopold CS
Drug Dev Ind Pharm; 2011 Mar; 37(3):320-8. PubMed ID: 20815796
[TBL] [Abstract][Full Text] [Related]
4. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
5. Modulation of drug release kinetics of shellac-based matrix tablets by in-situ polymerization through annealing process.
Limmatvapirat S; Limmatvapirat C; Puttipipatkhachorn S; Nunthanid J; Luangtana-anan M; Sriamornsak P
Eur J Pharm Biopharm; 2008 Aug; 69(3):1004-13. PubMed ID: 18362064
[TBL] [Abstract][Full Text] [Related]
6. Formulation and evaluation of a pulsatile drug delivery system using time- and pH-dependant polymers.
Kadam VD; Gattani SG
Pharm Dev Technol; 2010; 15(1):57-63. PubMed ID: 19552544
[TBL] [Abstract][Full Text] [Related]
7. Investigation of various shellac grades: additional analysis for identity.
Buch K; Penning M; Wächtersbach E; Maskos M; Langguth P
Drug Dev Ind Pharm; 2009 Jun; 35(6):694-703. PubMed ID: 19514984
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical applications of shellac: moisture-protective and taste-masking coatings and extended-release matrix tablets.
Pearnchob N; Siepmann J; Bodmeier R
Drug Dev Ind Pharm; 2003 Sep; 29(8):925-38. PubMed ID: 14570313
[TBL] [Abstract][Full Text] [Related]
9. Effect of core size and excipients on the lag time and drug release from a pulsatile drug delivery system.
Efentakis M; Iliopoyloy A; Siamidi A
Drug Dev Ind Pharm; 2011 Jan; 37(1):113-20. PubMed ID: 20615155
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the effect of various shellac coating compositions containing different water-soluble polymers on in vitro drug release.
Qussi B; Suess WG
Drug Dev Ind Pharm; 2005 Jan; 31(1):99-108. PubMed ID: 15704861
[TBL] [Abstract][Full Text] [Related]
11. Development of colon targeted multiparticulate pulsatile drug delivery system for treating nocturnal asthma.
Kadam VD; Gattani SG
Drug Deliv; 2010 Jul; 17(5):343-51. PubMed ID: 20429842
[TBL] [Abstract][Full Text] [Related]
12. Gastro-resistant characteristics of GRAS-grade enteric coatings for pharmaceutical and nutraceutical products.
Czarnocka JK; Alhnan MA
Int J Pharm; 2015; 486(1-2):167-74. PubMed ID: 25796126
[TBL] [Abstract][Full Text] [Related]
13. Visualization and analysis of the release mechanism of shellac coated ascorbic acid pellets.
Förmer P; Theurer C; Müller A; Schmidt PC
Pharmazie; 2006 Dec; 61(12):1005-8. PubMed ID: 17283657
[TBL] [Abstract][Full Text] [Related]
14. Effect of drug solubility on release behavior of calcium polysaccharide gel-coated pellets.
Sriamornsak P; Kennedy RA
Eur J Pharm Sci; 2007 Nov; 32(3):231-9. PubMed ID: 17889515
[TBL] [Abstract][Full Text] [Related]
15. Coatings from blends of Eudragit® RL and L55: a novel approach in pH-controlled drug release.
Wulff R; Leopold CS
Int J Pharm; 2014 Dec; 476(1-2):78-87. PubMed ID: 25239771
[TBL] [Abstract][Full Text] [Related]
16. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
Bando H; McGinity JW
Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of oleo-gum resin as directly compressible tablet excipient and release retardant.
Kumar P; Singh I
Acta Pol Pharm; 2010; 67(3):307-13. PubMed ID: 20524434
[TBL] [Abstract][Full Text] [Related]
18. Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy.
Tabasi SH; Moolchandani V; Fahmy R; Hoag SW
Int J Pharm; 2009 Dec; 382(1-2):1-6. PubMed ID: 19660535
[TBL] [Abstract][Full Text] [Related]
19. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
Rujivipat S; Bodmeier R
Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
[TBL] [Abstract][Full Text] [Related]
20. Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma.
Mastiholimath VS; Dandagi PM; Jain SS; Gadad AP; Kulkarni AR
Int J Pharm; 2007 Jan; 328(1):49-56. PubMed ID: 16942847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
